Clinical Trial Update: Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID)

View source ↗

Summary

A terminated clinical trial in the Democratic Republic of Congo (Palu-COVID) evaluated whether malaria infection provides protection against severe COVID-19. Re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Covid19, Paludism | Status: TERMINATED | Results posted: 2024-10-17